08:00 - 08:15
Catalyst & Precious Metals Reclaim
-Metallix

08:15 - 08:30
Enabling Technologies in Drug Development Services
-Porton Pharma Solutions Ltd. USA

08:30 - 08:45
Integrated, End to End CRDMO Chemistry Platform
-WuXi AppTec

08:45 - 09:00
New Sterile High Potency Drug Facility in France
-Carbogen Amcis

09:00 - 09:15
The Four Technology Pillars of Chiral Quest
-Chiral Quest

09:15 - 09:30
Commercializing Advanced Catalyst and Ligand Technologies
-Sinocompound

09:30 - 09:45
Fluorine Chemistry and Beyond
-AGC Pharma Chemicals

09:45 - 10:00
Isotopic Batch Process Understanding for Quality Control and Regulatory Compliance
-Nature’s Fingerprint / MIT LLC

10:00 - 10:15
Integrating Chemistry, CMC & Clinical Assessments to Accelerate Development Timelines
-Quotient Sciences

10:15 - 10:30
Lipids & Polymers for Biovailability Improvement
-SEQENS

10:30 - 10:45
Innovating New Technologies to Develop World Class Know-how to Support a Sustainable Future for PGMs
-PhosphonicS Ltd

10:45 - 11:00
Navigating Curiosity to Cure
-Curia Global

11:00 - 11:15
Integrated CRDMO Chemistry Platform
-WuXi AppTec and WuXi STA

11:15 - 11:30
From Discovery to Commercialization: The Importance of Chiral Separations
-Daicel Chiral Technologies

11:30 - 11:45
ChemCon: Good Manufacturing Partner – Organic, Inorganic, Polymers
-ChemCon

11:45 - 12:00
CRDMO Services from Concept to Commercialization
-BioDuro-Sundia

01:45 - 02:00
Manufacturing Large Scale HPAPI’s
-Evonik

02:00 - 02:15
The Art of Making Peptides
-BCN Peptides

02:15 - 02:30
IND Enabling CMC
-Exemplify Biopharma

02:30 - 02:45
Site Expansion Update – API Supply from Switzerland
-DOTTIKON

02:45 - 03:00
Applications of New Technology to API Development and Manufacture
-Almac Sciences

03:00 - 03:15
Enabling End-to-End Drug Development from IND-Enabling Through Product Launch
-CatSci

03:15 - 03:30
Revolutionizing Pharma Analysis: Unveiling the Power of SCIEX Mass Spec Solutions
-Sciex

03:30 - 03:45
Medicinal Chemistry at X-Chem: Our 10-Year Delivery Track Record Advancing Hits → Leads → Candidates For Our Clients
-X-Chem, Inc.

03:45 - 04:00
CDMO on the basis of Steroid Structure
-Hubei Goto Biopharm Co., Ltd.

04:00 - 04:15
The Emerging CDMO, BirdoTech
-BirdoTech

04:15 - 04:30
Early Phase Drug Substance Adaptability
-Lonza

04:30 - 04:45
Keeping it Local... Grace’s 40 Year History Producing Fine Chemicals in the USA
-W.R. Grace & Co.

04:45 - 05:00
Advanced intermediates from Korea
-Green Life Science

05:00 - 05:15
Getting Your Small Molecule to the Clinic
-Concept Life Sciences

08:15 - 08:30
Helping Small & Virtual Pharma on their Journey
-Flamma USA

08:30 - 08:45
Alcami – Your Solid-State Characterization Partner
-Alcami Corporation

08:45 - 09:00
A Small Molecule CRO/CDMO
-Medinoah

09:00 - 09:15
Fermion – Your Nordic CDMO Partner
-Fermion, a subsidiary of Orion Corporation

09:15 - 09:30
A New Innovative Player in Small Molecule Development and Manufacturing
-Chemelectiva

09:30 - 09:45
Integrated Lifecycle Strategy for an Excellent CDMO Service
-Moehs Fine Chemicals

09:45 - 10:00
Driving Innovation in Small Molecule Process Chemistry: AcceleDev's Custom Synthesis Solutions
-AcceleDev

10:00 - 10:15
Expediting Drug Substance Development and Manufacturing
-Regis Custom Pharma

10:15 - 10:30
Fueling Future Growth: New CDMO Sites and Capacity Expansion for API and HPAPI
-Minakem

10:30 - 10:45
SGRL: Reliable Manufacturer - Halogenation & Reduction
-Shree Ganesh Remedies Limited

10:45 - 11:00
Deliver Quality to Accelerate Drug Discovery and Development
-Chemexpress

11:00 - 11:15
Breaking Paradigms Through Deuterium Chemistry
-Clearsynth

11:15 - 11:30
Biocatalytic Manufacturing of API Intermediates Using Engineered Enzymes
-Enzymaster